检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:陈进 林令琪 钱昆 赵亮 CHEN Jin;LIN Lingqi;QIAN Kun;ZHAO Liang(College of Pharmacy,Jinzhou Medical University,Jinzhou 121000;College of Public Foundation,Jinzhou Medical University,Jinzhou 121000)
机构地区:[1]锦州医科大学药学院,辽宁锦州121000 [2]锦州医科大学公共基础学院,辽宁锦州121000
出 处:《中国医药工业杂志》2023年第1期75-84,共10页Chinese Journal of Pharmaceuticals
基 金:辽宁省教育厅课题(JYTJCZR2020067)。
摘 要:该研究通过搅拌加热的方法首次成功制备了以腺嘌呤为有机配体、金属钛为核心的生物型金属有机骨架(MOF),Ti-MOF-79,并以槲皮素(1)为药物模型对Ti-MOF-79的载药、释药性能进行研究。通过扫描电镜(SEM)、X射线衍射(XRD)、差示扫描量热(DSC)、X射线光电子能谱(XPS)、红外光谱(IR)、紫外光谱(UV)和细胞毒性试验等方法对该材料和载药复合物进行表征,并计算了载药量及累积释放率。结果表明Ti-MOF-79是一种规则的圆柱体形晶体,具有多孔结构,载药量为(28.83±8.35)%,在体外具有一定的缓释作用,且无明显的细胞毒性,提示MOF有望成为新型载体材料。The biological metal-organic framework(MOF)Ti-MOF-79 with adenine as an organic ligand and Ti as a metal core was synthesized under hydrothermal conditions.Quercetin(1)was used as a drug model to investigate the drug loading and release performance of Ti-MOF-79.The material and the drug-loaded complexes were characterized through transmission electron microscopy(SEM),X-ray diffractometry(XRD),differential scanning calorimetry(DSC),X-ray photoelectron spectroscopy(XPS),infrared spectroscopy(IR),ultraviolet spectroscopy(UV)and cytotoxicity test,and the drug loading and cumulative release rates were calculated.The results showed that Ti-MOF-79 was a regular long cylindrical crystal with porous structure.The results of in vitro experiments showed that the complexes with drug loading of(28.83±8.35)%had a sustained-release profile and had no obvious cytotoxicity,which indicated that MOF could become a novel carrier material.
分 类 号:R945[医药卫生—微生物与生化药学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.49